David Bolon
Opted out of Medicare from April 2025 to April 2027. Internal Medicine, Cardiovascular Disease in New York, New York, trained at New York University School of Medicine (class of 1996). In 2024 Medicare paid $523,735 for 732 patients, and Part D covered 3,561 of their prescriptions, 81% of them generic. Novo Nordisk Inc was the largest of 8 companies reporting payments in 2025, $191.27 in all, mostly food and beverage.
Overview
| NPI | 1033184205 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Sole proprietor | No |
| NPI issued | Feb 21, 2006 |
| Last updated in NPPES | May 25, 2022 |
| Certified by provider | May 9, 2022 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Cardiovascular Disease Primary | 207RC0000X | 208240 | NY |
| Nuclear Medicine, Nuclear Cardiology | 207UN0901X | 208240 | NY |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Apr 1, 2025 – Apr 1, 2027 |
| Can order and refer | Yes |
| Accepts assignment | Yes (participating) |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Medicare services in 2024
| Medicare patients | 732 |
|---|---|
| Services billed | 4,777 across 27 procedure codes |
| Paid by Medicare | $523,735 |
Part D prescriptions in 2024
| Prescriptions (claims) | 3,561 · 9,136 30-day fills |
|---|---|
| Patients | 471 |
| Total drug cost | $717,736 |
| Generic share | 81% of claims |
Education and affiliations
| Medical school | New York University School of Medicine |
|---|---|
| Graduation year | 1996 |
| Medicare specialty | Cardiovascular Disease (Cardiology) |
| Secondary specialties | Internal Medicine, Nuclear Medicine |
Industry payments (Open Payments)
- 2025$191.27 · 10 payments from 8 companies
- 2024$616.46 · 22 payments from 11 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $42.06 | 2 |
| Pfizer Inc. | $27.05 | 1 |
| Amgen Inc. | $26.55 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.44 | 2 |
| Actelion Pharmaceuticals US, Inc. | $20.50 | 1 |
What the 2025 payments were for
- Food and Beverage$191.27 · 10 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Cardiovascular Disease providers in New York
- 1770208076
- 1700780202
- 1396160917
- 1912549262
- 1851533921
- 1366530172
- 1871862938
- 1689761264
- 1417019761
- 1427773068
- 1669142055
- 1386891539
All Internal Medicine, Cardiovascular Disease providers in New York →